SCHEMBL6655830

SCHEMBL6655830

Cc1ccc(Nc2ccc(C(=O)c3ccccc3C)c(Cl)c2)c(N)c1

nearest known ligand 0.80

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 17/20 0.80
MAPK13 O15264 16/20 0.80
MAPK12 P53778 16/20 0.80
MAPK11 Q15759 16/20 0.80
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
KDM4E B2RXH2 1/20 0.44
NPC1 O15118 1/20 0.44
GAA P10253 1/20 0.44
MAPT P10636 1/20 0.44
GFER P55789 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
GRM4 Q14833 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7211089 0.91 MAPK14 (0.80) MAPK14MAPK13MAPK12MAPK11KDM4E
SCHEMBL2201099 0.89 MAPK14 (1.00) MAPK14MAPK13MAPK12MAPK11GAA
SCHEMBL745376 0.89 MAPK14 (1.00) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL29432589 0.89 MAPK14 (1.00) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL6824925 0.89 MAPK14 (0.81) MAPK14MAPK13MAPK12MAPK11
SCHEMBL7192939 0.87 MAPK14 (0.74) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL7190935 0.86 MAPK14 (0.72) MAPK14MAPK13MAPK12MAPK11MEN1
SCHEMBL1904637 0.84 MAPK14 (1.00) MAPK14MAPK13MAPK12MAPK11
SCHEMBL7199715 0.84 MAPK14 (0.80) MAPK14MAPK13MAPK12MAPK11KDM4E
SCHEMBL6396535 0.83 MAPK14 (0.78) MAPK14MAPK13MAPK12MAPK11MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3081568-B1 COMPOSITIONS AND METHODS FOR TREATING ALZHEIMER'S DISEASE EIP PHARMA LLC (US) 2019-11-13 EP disclosed
EP-0966424-B1 AMINOBENZOPHENONES AS INHIBITORS OF INTERLEUKIN AND TNF LEO PHARMA AS (DK) 2004-06-23 EP disclosed
US-6313174-B1 FOR THERAPY AND PROPHYLAXIS OF ASTHMA, ALLERGY, RHEUMATOID ARTHRITIS, SPONDYLOARTHRITIS, GOUT, ATHEROSCLEROSIS, CHRONIC INFLAMMATORY BOWEL DISEASE, PROLIFERATIVE AND INFLAMMATORY SKIN DISORDERS Leo Pharmaceutical Products Ltd.A/S/ (Løvens kemiske Fabrik Produktionsaktieselskab) (DK) 2001-11-06 US disclosed